Y-Intercept (HK)’s NeoGenomics NEO Stock Holding History

Y-Intercept (HK)’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-139,809	Closed	-$1.04M	–	2019
2026 Q1	$1.04M	Buy	139,809 +56,284	+67%	+$592K	0.02%	1017
2025 Q4	$982K	Sell	83,525 -82,365	-50%	-$889K	0.02%	988
2025 Q3	$1.28M	Buy	+165,890	New	+$1.16M	0.03%	851
2024 Q1	–	Sell	-38,520	Closed	-$623K	–	1629
2023 Q4	$623K	Buy	38,520 +28,460	+283%	+$466K	0.06%	495
2023 Q3	$124K	Buy	+10,060	New	+$150K	0.01%	951
2023 Q1	–	Sell	-43,786	Closed	-$405K	–	1418
2022 Q4	$405K	Buy	43,786 +29,473	+206%	+$275K	0.06%	518
2022 Q3	$123K	Buy	+14,313	New	+$142K	0.01%	871
2022 Q2	–	Sell	-57,929	Closed	-$704K	–	1081
2022 Q1	$704K	Buy	+57,929	New	+$1.22M	0.16%	181
2021 Q2	–	Sell	-6,905	Closed	-$309K	–	802
2021 Q1	$309K	Buy	+6,905	New	+$359K	0.08%	389

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Y-Intercept (HK)'s NEO Position: Q2 2026 in Review

Y-Intercept (HK) sold out of NeoGenomics (NEO) in Q2 2026, closing a stake of 139,809 shares — an estimated $1.04M sold.

Y-Intercept (HK) first reported a position in NEO in Q1 2021 and held it in 9 quarters. The position peaked at $1.28M in Q3 2025. 267 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

Y-Intercept (HK) reported no remaining NeoGenomics position as of Q2 2026 after selling out during the quarter.
Y-Intercept (HK) sold 139,809 NeoGenomics shares in Q2 2026, an estimated $1.04M.
Y-Intercept (HK) first reported a position in NeoGenomics in Q1 2021 and held it in 9 quarters.
Y-Intercept (HK)'s NeoGenomics position peaked at $1.28M in Q3 2025.
267 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.